News

14
Sep

Sanofi Pharmaceutical Company’s First Clinical Trial Approved Through CATALIS Quebec’s FAST TRACK Evaluation Service

Sanofi Pharmaceutical Company’s First Clinical Trial Approved Through CATALIS Quebec’s FAST TRACK Evaluation Service   Following Novartis, Boehringer, and Roche, Sanofi is now CATALIS’ fourth pharmaceutical partner to pilot its FAST TRACK Evaluation Service. Sanofi’s Phase I-ll study, which uses human subjects for the first time and is designed to assess the safety and the pharmacokinetic, pharmacodynamic, and antitumor activity

Read more

14
Sep

Roche Pharmaceutical Company’s First Clinical Trial Approved Through CATALIS Quebec’s FAST TRACK Evaluation Service

Roche Pharmaceutical Company’s First Clinical Trial Approved Through CATALIS Quebec’s FAST TRACK Evaluation Service   Thanks to CATALIS’ FAST TRACK evaluation service, Roche’s ProHer multi-centre study, which explores a new treatment method for patients with breast cancer, was approved in 10 weeks by the CHU de Québec-Université Laval. More specifically, this study seeks to discover patients’ preference for at-home administration

Read more

20
Jun

CATALIS Quebec Partners With N2 Canada for Provincial Contract Access to the CITI-Canada Training Platform

CATALIS Quebec Partners With N2 Canada for Provincial Contract Access to the CITI-Canada Training Platform   CATALIS Quebec is very proud to partner with N2 Canada to provide its Network member healthcare institutions access to a shared training platform designed to ensure the conduct of high-quality research: the CITI-Canada training platform. Through this partnership, CATALIS Quebec officially becomes the new

Read more

19
May

Two New Projects Successfully Authorized Within Seven Weeks Thanks to CATALIS QUEBEC’S FAST TRACK Evaluation Service

Two New Projects Successfully Authorized Within Seven Weeks Thanks to CATALIS QUEBEC’S FAST TRACK Evaluation Service   While the first-ever FAST TRACK evaluation service pilot project was successfully completed last December, CATALIS is proud to announce that two more clinical trials have now been approved in record time. The second FAST TRACK evaluation service coordinated a Phase I oncology study

Read more

19
May

Launch of New Shared Clinical Research Tools

Launch of New Shared Clinical Research Tools CATALIS and its network of public and private partners have facilitated the implementation of new shared tools designed to optimize the launching and conducting of clinical trials in Quebec; more specifically, CATALIS has coordinated the revision of documents serving to optimize the contract negotiation process with private industry and a memo which serves to

Read more

11
Apr

Danika Laberge Has Been Appointed President and Chief Executive Officer of CATALIS Quebec

Danika Laberge Has Been Appointed President and Chief Executive Officer of CATALIS Quebec   CATALIS Quebec’s Board of Directors is pleased to announce the appointment of Danika Laberge as the organization’s President and Chief Executive Officer (CEO). “It is with tremendous enthusiasm and confidence in her abilities that the Board of Directors has appointed Ms. Laberge to the position of

Read more

10
Apr

Job Offer : Project Manager

We’re looking for a Project Manager who will help implement and conduct activities related to the FAST TRACK evaluation service for clinical trials in Québec. To view the job offer, click here.

16
Mar

CATALIS Quebec’s Network of Partners Now Includes 23 Quebec Health Institutions

CATALIS Quebec’s Network of Partners Now Includes 23 Quebec Health Institutions   In keeping with its new government mandate of bringing together clinical research stakeholders, CATALIS Quebec is pleased to announce that it is expanding the scope of its activities to a larger number of institutions in the province: it has added 23 public institutions from Quebec’s health and social

Read more

16
Mar

Two New Administrators Join the CATALIS Board of Directors

Two New Administrators Join the CATALIS Board of Directors Dr. Guy A. Rouleau Dr. Guy Rouleau is Director of The Neuro (Montreal Neurological Institute-Hospital), Chair of the Department of Neurology and Neurosurgery of McGill University, Director of the Department of Neuroscience of McGill University Health Centre, and co-founder of the Tanenbaum Open Science Institute. He was recently elected Vice-President of

Read more

16
Mar

In recognition of Dr. Jacques Michaud and Dr. Michael Sebag for their work on the CATALIS Quebec Board of Directors

In recognition of Dr. Jacques Michaud and Dr. Michael Sebag for their work on the CATALIS Quebec Board of Directors   After three years on the CATALIS Board of Directors, Dr. Jacques Michaud is now stepping down. On behalf of the CATALIS Board of Directors, I would like to acknowledge Dr. Michaud’s professionalism and dedication, and to thank him for

Read more